Cargando…
HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
HDAC5 is a class IIa histone deacetylase member that is downregulated in multiple solid tumors, including pancreatic cancer, and loss of HDAC5 is associated with unfavorable prognosis. In this study, assessment of The Cancer Genome Atlas pancreatic adenocarcinoma dataset revealed that expression of...
Autores principales: | Pan, Penglin, Qin, Gengdu, Wang, Bo, Yu, Haixin, Chen, Jie, Liu, Jiaying, Bing, Kaijian, Shen, Jian, Ren, Dianyun, Zhao, Yuhan, Xia, Wentao, Li, Hui, Wu, Heshui, Zhou, Yingke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755957/ https://www.ncbi.nlm.nih.gov/pubmed/36102738 http://dx.doi.org/10.1158/0008-5472.CAN-21-4362 |
Ejemplares similares
-
HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer
por: Zhou, Yingke, et al.
Publicado: (2022) -
Inhibition of the MEK1/ERK pathway reduces arachidonic acid release independently of cPLA(2) phosphorylation and translocation
por: Evans, John H, et al.
Publicado: (2002) -
Prognostic Analysis of Different Metastatic Patterns in Invasive Intraductal Papillary Mucinous Neoplasm: A Surveillance, Epidemiology, and End Results Database Analysis
por: Zhou, Chen, et al.
Publicado: (2021) -
Novel role of cPLA(2)α in membrane and actin dynamics
por: Moes, Maarten, et al.
Publicado: (2010) -
cPLA(2)α Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation
por: Ashcroft, Felicity J., et al.
Publicado: (2020)